Among the group of S-MEN1 patients who tested negative for MEN1 mutations (80%), 82% had two main MEN1-related lesions (70% of them had PHPT and pituitary adenoma, and 30% had PHPT and GEP), whereas the remaining 18% had the classical triad. This evidence concerns the gene MEN1 and pituitary gland adenoma.